Filing Details
- Accession Number:
- 0001127602-18-025295
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-14 16:07:41
- Reporting Period:
- 2018-08-10
- Accepted Time:
- 2018-08-14 16:07:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1441876 | Mostafa Ronaghi | 5200 Illumina Way San Diego CA 92122 | Sr Vp & Cto | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-10 | 10,000 | $37.04 | 80,805 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-10 | 3,463 | $330.29 | 77,342 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-10 | 2,600 | $331.38 | 74,742 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-10 | 3,737 | $332.32 | 71,005 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-10 | 200 | $333.10 | 70,805 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2018-08-10 | 10,000 | $0.00 | 10,000 | $37.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,000 | 2010-02-27 | 2020-01-27 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 3,463 shares sold ranging from $329.81 to $330.80 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 2,600 shares sold ranging from $330.89 to $331.84 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 3,737 shares sold ranging from $331.90 to $332.79 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 200 shares sold ranging from $333.04 to $333.15 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
